Latest filing published 15 Jan 2026 for ODI Pharma AB (publ), €3,502.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Johan Edewaard: trading record in brief
Johan Edewaard is a declared insider of ODI Pharma AB (publ) (chief executive), with filings sourced from Finansinspektionen. Over a trading history stretching from 5 January 2026 to 8 January 2026, the count stands at 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €4,465). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 15 January 2026: an open-market purchase of €963, in ODI Pharma AB (publ). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Johan Edewaard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ €0.35020.088% mcap100.0% of flowAktieISIN SE0013409760FI:A003V318-1Canonical exit: 8 Apr 2026 (T+90)
1 of 1 declaration